| P50 | author | Raymond P. Donnelly | Q40102325 |
| | Natalia A Ilyushina | Q88307363 |
| P2093 | author name string | Nicolai V Bovin | |
| | Vladimir Y Lugovtsev | |
| | Faruk G Sheikh | |
| | Anastasia P Samsonova | |
| P2860 | cites work | Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I | Q24312113 |
| | IL-28, IL-29 and their class II cytokine receptor IL-28R | Q24323830 |
| | IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex | Q24336912 |
| | Perspectives on antiviral use during pandemic influenza | Q24522384 |
| | Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells | Q24559989 |
| | Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1 | Q26700091 |
| | Influenza treatment and prophylaxis with neuraminidase inhibitors: a review | Q26860032 |
| | Functional balance of the hemagglutinin and neuraminidase activities accompanies the emergence of the 2009 H1N1 influenza pandemic | Q27681276 |
| | The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza | Q28263414 |
| | Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern | Q28275022 |
| | H5N1 influenza--continuing evolution and spread | Q28275423 |
| | Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses | Q28473051 |
| | Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 |
| | A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice | Q28609778 |
| | Human infection with a novel avian-origin influenza A (H7N9) virus | Q29620049 |
| | A DNA transfection system for generation of influenza A virus from eight plasmids | Q29642855 |
| | The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. | Q30353368 |
| | Protection from lethal influenza virus challenge by oral type 1 interferon. | Q30360002 |
| | Multiple anti-interferon actions of the influenza A virus NS1 protein | Q30361157 |
| | In vitro anti-influenza A activity of interferon (IFN)-λ1 combined with IFN-β or oseltamivir carboxylate. | Q30367054 |
| | Viral suppressors of the RIG-I-mediated interferon response are pre-packaged in influenza virions | Q30369504 |
| | The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. | Q30369723 |
| | Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding | Q30374356 |
| | Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. | Q40319046 |
| | Mechanism of action of T-705 against influenza virus | Q41091905 |
| | Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate | Q41720424 |
| | ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE). | Q45153220 |
| | Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides | Q45776103 |
| | A solid-phase enzyme-linked assay for influenza virus receptor-binding activity | Q45870959 |
| | Observed oseltamivir resistance in seasonal influenza viruses in Europe interpretation and potential implications. | Q46620147 |
| | Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe | Q46620149 |
| | Type I IFN modulates innate and specific antiviral immunity. | Q52920823 |
| | Universal primer set for the full-length amplification of all influenza A viruses | Q57202943 |
| | High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR | Q80646005 |
| | The resurgence of swine-origin influenza A (H1N1). | Q30377754 |
| | Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. | Q30382867 |
| | In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses | Q30387420 |
| | Adaptation of pandemic H1N1 influenza viruses in mice | Q30390936 |
| | Pandemic 2009 H1N1 influenza virus is resistant to the antiviral activity of several interferon alpha subtypes | Q30398590 |
| | Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States | Q30400342 |
| | Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium | Q30413673 |
| | Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential | Q30417679 |
| | Interferon induction and function at the mucosal surface | Q30661545 |
| | IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo | Q33325913 |
| | Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses | Q33369068 |
| | T-705 (favipiravir) activity against lethal H5N1 influenza A viruses | Q33639979 |
| | Plaque inhibition assay for drug susceptibility testing of influenza viruses | Q33729018 |
| | Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein | Q33810694 |
| | Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections | Q33877293 |
| | The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein | Q33939684 |
| | The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon | Q34055501 |
| | Functional balance between haemagglutinin and neuraminidase in influenza virus infections | Q34126466 |
| | Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection | Q34187313 |
| | Interactions between the influenza A virus RNA polymerase components and retinoic acid-inducible gene I. | Q34262049 |
| | Epidemiology of human infections with avian influenza A(H7N9) virus in China. | Q34341070 |
| | RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids | Q34361738 |
| | IFN-λ4: the paradoxical new member of the interferon lambda family | Q34439917 |
| | Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide | Q34637724 |
| | Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate | Q34971083 |
| | Interferon-lambda and therapy for chronic hepatitis C virus infection | Q35186389 |
| | Replication fitness determines high virulence of influenza A virus in mice carrying functional Mx1 resistance gene | Q35800387 |
| | Interferon-lambda (IFN-λ) induces signal transduction and gene expression in human hepatocytes, but not in lymphocytes or monocytes | Q36628598 |
| | Early control of H5N1 influenza virus replication by the type I interferon response in mice. | Q37191923 |
| | Influenza A polymerase subunit PB2 possesses overlapping binding sites for polymerase subunit PB1 and human MAVS proteins. | Q39224928 |
| | Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon | Q39593618 |
| | Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1. | Q39669004 |
| | The influenza A virus NS1 protein inhibits activation of Jun N-terminal kinase and AP-1 transcription factors | Q39685168 |
| | Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa | Q39973215 |
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0181999 | |
| P577 | publication date | 2017-07-27 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses | |
| P478 | volume | 12 | |